Search results

300 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
CF Foundation honors UNC researchers for vital treatment
Hypertonic saline, developed into an effective treatment at UNC School of Medicine in collaboration with Australian researchers, has become a proven therapy for thousands of people with cystic fibrosis.
Located in News / 2014 / October
Chelminski Elected Councilor into the Association for Program Directors in Internal Medicine
Paul Chelminski, MD, MPH, a graduate from the UNC School of Medicine, is an associate professor of medicine and Associate Program Director for Outpatient Education.
Located in Vital Signs / 2013 / March 14
Chelminski, Meltzer-Brody named first Sanders Clinician Scholars
As the first two Sanders Clinician Scholars, Paul Chelminski, MD, MPH, and Samantha Meltzer-Brody, MD, MPH, will develop educational efforts to enhance supportive direct personal contact in the daily care of patients, and to teach others to do the same.
Located in News / 2012 / May
Chronic low back pain on the rise: UNC study finds 'alarming increase' in prevalence
The proportion of people suffering from long term, impairing low back pain has more than doubled in North Carolina since the early 1990s, according to a new study.
Located in Vital Signs / 2009 / February
Ciccone Receives Burroughs Wellcome Fund/ASTMH Postdoctoral Fellowship in Tropical Infectious Diseases Award
Emily Ciccone, MD, MHS, a clinical instructor and fellow of infectious diseases in the UNC Department of Medicine, will use the fellowship to develop a new diagnostic test to identify Brucella as a cause of pediatric febrile illness in Kasese, Uganda.
Located in Vital Signs / 2020 / Jan. 9
Ciccone receives Thrasher Research Foundation Early Career Award
Emily Ciccone, MD, MHS, will use the $25,000 award to differentiate viral and bacterial respiratory infections among malaria-negative children. The overall goal is to reduce unnecessary antibiotic use without compromising safety in an area where access to care is a real issue.
Located in Vital Signs / 2019 / June 13
Consortium identifies genome regions that could influence severity of cystic fibrosis
A team of researchers, including a number from the University of North Carolina at Chapel Hill School of Medicine, have pinpointed regions of the genome that contribute to the debilitating lung disease that is the hallmark of cystic fibrosis.
Located in News / 2011 / May
CRISPR gene editing makes stem cells 'invisible' to immune system
UNC School of Medicine researchers from the lab of J. Victor Garcia-Martinez, PhD, are co-authors of a study on the creation of pluripotent stem cells that avoided transplant rejection in lab studies.
Located in News / 2019 / February
Cystic fibrosis gene typo is a double whammy
Researchers at the University of North Carolina at Chapel Hill School of Medicine have demonstrated that the gene mutated in cystic fibrosis not only controls traffic on the chloride highway, but also keeps the sodium highway from being overused.
Located in News / 2010 / November
Daniel Kaufer and Philip Sloane receive grants to improve Alzheimer's care
Drs. Kaufer and Sloane have been awarded a $540,000, three-year grant for a project aimed at increasing the number of doctors in North Carolina with expertise in treating patients with Alzheimer’s dementia.
Located in Vital Signs / 2008 / October